Anne-laure L. Villing
Auxerre, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort.
Journal: JHEP reports : innovation in hepatology
Published: October 20, 2025
Circulating Tumor DNA Dynamics and Clinical Outcomes in Patients with Advanced Colorectal Cancer Treated with Cetuximab-Based Induction and Maintenance Treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 22, 2025
Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study.
Journal: Oncology letters
Published: February 21, 2025
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
Journal: JAMA network open
Published: September 18, 2023
Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis.
Journal: Hepatology international
Published: September 29, 2020
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma.
Journal: Journal of hepatology
Published: October 30, 2018
Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: August 27, 2018
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Journal: Oncotarget
Published: March 08, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026